AXE 5.56% 25.5¢ archer materials limited

Ann: Biochip experiments begin to develop kidney disease testing, page-35

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 484 Posts.
    lightbulb Created with Sketch. 826
    I would have thought so, yes. But since this announcement mentions CKD and coincidentally CKD trial is latest, and since the sponsor hasn't been named, the gFET maybe being tested in the background. Anyway I'm only saying it might be connected. Eventually this is the type of trial and timeline we can definitely expect.

    Too much of a coincidence? 6 NSW public hospitals?
 
watchlist Created with Sketch. Add AXE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.